5 Einträge gefunden

1. Occurrence and characteristics of patients with de novo advanced breast cancer according to patient and tumor characteristics - A retrospective analysis of a real world registry

   1. Müller, Volkmar
   2. Hein, Alexander
   3. Hartkopf, Andreas D
   4. Fasching, Peter A
   5. Kolberg, Hans-Christian
   6. Hadji, Peyman
   7. Tesch, Hans

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
2. Prognostic effect of low-level HER2 expression in patients with clinically negative HER2 status

   1. Hein, Alexander
   2. Hartkopf, Andreas D
   3. Emons, Julius
   4. Lux, Michael P
   5. Volz, Bernhard
   6. Taran, Florin-Andrei
   7. Overkamp, Friedrich

   2021 - Forschungsinformationssystem des UKE
3. Efficacy of neoadjuvant pertuzumab in addition to chemotherapy and trastuzumab in routine clinical treatment of patients with primary breast cancer: a multicentric analysis

   1. Fasching, Peter A
   2. Hartkopf, Andreas D
   3. Gass, Paul
   4. Häberle, Lothar
   5. Akpolat-Basci, Leyla
   6. Hein, Alexander
   7. Volz, Bernhard

   2019 - Forschungsinformationssystem des UKE
4. Using Probability for Pathological Complete Response (pCR) as a Decision Support Marker for Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Patients - a Survey Among Physicians

   1. Gass, Paul
   2. Untch, Michael
   3. Müller, Volkmar
   4. Möbus, Volker
   5. Thomssen, Christoph
   6. Häberle, Lothar
   7. Erber, Ramona

   2018 - Forschungsinformationssystem des UKE
5. Genetic variants in VEGF pathway genes in neoadjuvant breast cancer patients receiving bevacizumab: Results from the randomized phase III GeparQuinto study

   1. Hein, Alexander
   2. Lambrechts, Diether
   3. von Minckwitz, Gunter
   4. Häberle, Lothar
   5. Eidtmann, Holger
   6. Tesch, Hans
   7. Untch, Michael

   2015 - Forschungsinformationssystem des UKE